Don't underestimate the value of learning how to deal with that emerging threat.
The data is truly superb, but we can't get distracted by the stock surging up or down. Drug development is a long, tortuous path, and if you lose your focus you get lost in the woods.
The conventional vaccine works only for the antibodies, which are (the) bullets. Our vaccine goes after antibodies and D-cells -- the soldiers. So you have the soldiers and the bullets, which could actually go after the pathogen.
If we pick the wrong pathogen to develop a vaccine and a new strain comes out, then vaccine development is futile.
